Africa CDC says countries yet to report the ‘South African’ variant should use AstraZeneca vaccine

0
102
The Oxford-AstraZeneca vaccine only offers limited protection against the variant first discovered in South Africa, new data suggests. /AP
The Oxford-AstraZeneca vaccine only offers limited protection against the variant first discovered in South Africa, new data suggests. /AP

In Thursday’s Africa CDC weekly COVID-19 briefing, Director Dr. John Nkengasong has announced that African countries that have not reported the circulation of the 501Y.V2 Coronavirus variant which was first identified in South Africa should proceed with the rollout and usage of the AstraZeneca COVID-19 vaccine.

The director further said that for countries that have reported circulation of the 501Y.V2 variant, they should accelerate their preparedness to introduce all vaccines that have received emergency use authorization.

Nkengasong however said that consideration should be given to the effectiveness of the vaccine against the 501Y.V2 variant.

Leave a Reply